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Introduction
A large percentage of  infants (early age) face congenital visual 
impairments that persist throughout adult life and remain uncur-
able. Most common neonatal eye defects at global level are related 
to structure and function of  cornea, lens, retina, optic nerve and 
visual cortex in the brain. Approximately more than 300 million 
people bear congiental defects and suffer from various eye diseas-
es such as cataracts, glaucoma, age-related macular degeneration, 
diabetic retinopathy, and corneal diseases. Out of  these, roughly 
10 million people suffer from severe ocular surface diseases. Such 
cases are reported from developing countries only. Vision inca-
pacitation, blindness and retinal degeneration, glaucoma, macular 
degeneration, and retinitis pigmentosa, cataracts, aneurosis, age-
optic neuritis, retinitis pigmentosa, strabismus are important neo-
natal eye defects [1]. There are many congenital anomalies such as 
anophthalmos, microphthalmos, coloboma, congenital cataract, 
infantile glaucoma, and neuro-ophthalmic lesions which are diag-
nosed at birth. Other impairments like ophthalmia neonatorum, 
retinopathy of  prematurity and cortical visual impairment are ac-
quired during the perinatal period. Leukocoria or white pupillary 
reflex can be caused by congenital cataract, persistent hyperplastic 
primary vitreous, or retinoblastoma. Retinal haemorrhage [2] and 
spontaneous corneal perforation are also noted in neonates [3]
(Table 1) (Figure 2). 
Most of  the congenital disorders originate during embryonic de-
velopment due to adverse effect of  environmental mutagenes, 
drugs, and gene mutations. Few of  them could be partially re-
stored by using stem cell transplantation therapy but most of  
mechanical-physical-physiological defects give rise to permanent 
defects/impairments and remain non restorable. Few congenital 
eye malformations are curable but replacement of  any part of  eye 
is too difficult to obtain a suitable transplant. Eye functions like 
a photographic camera wherein replacement of  any component 
of  camera is easy, but is very difficult in case of  eye a visual pho-
toreceptor. Any physiological and structural impairment in one 
or more eye component obstructs its normal function (Figure 1). 
Normally an electronic part of  a camera could be replaced, but a 
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new biological component of  the eye is not easy to replace (trans-
plantation). 
Dry eye syndrome (DES) is one of  the most common ocular dis-
eases that represent impaired vision or even blindness in neonates 
and adult children. Few neonatal eye defects are highly compli-
cated and persist lifelong and remain untreatable. Best example is 
Joubert syndrome and related disorders which are caused due to 
complex midbrain-hindbrain malformation [4]. There are few rare 
defects such as Ankyloblepharon-ectodermal dysplasia-clefting 
(AEC) [5] (Table 1), persistent fetal vasculature [6], nasolacrimal 
duct obstruction [7], hypomyelination, congenital cataract (HCC), 
and neonatal corneal opacities (NCO) are most common visual 
impairments noted in infants [8] (Figure 2). Oculo-auriculo-verte-
bral spectrum is a complex developmental disorder that perpetu-
ates defects in ear, hemifacial microsomia, epibulbar dermoids 
and vertebral anomalies. Other neonatal diseases like popliteal 
pterygia, syngnathia, cleft lip and palate, retrognathia and pop-
liteal pterygium syndrome (PPS) are also rare defects found in in-
fants [9]. Gene mutation causes severe physiological diseases like 
respiratory distress, including tachypnea, nasal flaring, grunting, 
retractions, cyanosis, and craniosynostosis in infants [10]. Con-
genital microphthalmia is a rare disorder shows defects in primary 
optic vesicle [11]. (Table 1) (Figure 2).
 
At global level important congenital eye defects i.e. anophthala-
mos, congenital cystic eye, coloboma, nanophthalmos and mi-
crophthalmos are recorded. There are certain defects of  eye lid 
such as congenital ptosis, eyelid coloboma, and cryptophthalmos. 
There are certain defects of  eye lid such as congenital ptosis, eye-
lid coloboma, Cryptophthalmos; cornea i.e. congenital glaucoma 
(most common with an abnormally large eye), endothelial devel-
opment abnormalities, Persistent attachment of  lens, intrauterine 
inflammation, interstitial keratitis, megalocornea. Defects of  iris 
and pupil are corectopia, polycoria, and coloboma of  iris, aniridia, 
and albinism, heterochromia while defects of  lens are congenital 
cataracts, glaucoma and anisometropia. Other lens and anterior 
segment defects, vitrous defects are also observed such as leu-
kocoria and severe posterior uveitis/vitritis. Defects of  choroid 
and retina, central coloboma of  the disc, optic nerve hypoplasia 
and few extra ocular defects such as dermoids, conjunctivitis and 
dacryocystitis, craniofacial anomalies are also seen. There are also 
problems of  poor vision with no apparent cause. Congenital glau-
coma is often bilateral and associated with other defects. It is the 
most common non-syndromic glaucoma in infancy. The most 
characteristic ocular findings associated with congenital infection 
are chorioretinal scars and chorioretinitis. Genetic disorders are 
a leading cause of  visual impairment in children. They include 
anophthalmia, aniridia, albinism, anterior segment dysgenesis, 
Marfan’s syndrome, ectopia lentis, neurofibromatosis, retinal he-
mangioblastomas and familial exudative vitreoretinopathy.
Neonatal progeroid syndrome (NPS) and Pierson syndrome are 
rare autosomal recessive disorders which are related with diverse 
defects. NPS implies effects like bilateral upper eyelid entropion 
and stromal keratitis [12] (Table 1) while Pierson syndrome is re-
Figure 1. Eye is a complex organ made up of  layers of  different cell types.
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Figure 2. Showing various neonatal eye diseases which causes visual impairment in new born and infants.
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lated to congenital nephritic defects, diffuse mesangial sclerosis, 
microcoria and retinal haemorrhages [13]. Disease like incontinen-
tia pigmenti is a rare X-linked multisystem disorder that implies 
periventricular and subcortical white matter problems, haemor-
rhagic changes, corpus callosum hypoplasia, cerebral atrophy and 
cerebellar hypoplasia [14]. Few disorders like Alexander disease 
and mitochondrial leukoencephalopathies show myriad of  symp-
toms and signs which perist from neonatal age to adulthood. Both 
diseases display white matter changes, signaling defects of  basal 
ganglia or thalami and brainstem [15]. Oculo-auricular syndrome 
(OAS) in humans is caused due to mutation at HMX1 locus [16]. 
Ectrodactyly-ectodermal-dysplasia-cleft-syndrome results in vi-
sion loss and complete ophthalmic shutdown in early age pateints 
[17] (Table 1). 
Common neonatal eye defects are bilateral congenital cataract 
[18], embryonic retina regress [19], nystagmus, opticus atrophy, 
and strabismus [20] and glaucoma [21]. Loss of  corneal transpar-
ency is also seen in infants at birth or soon after <4 weeks of  birth 
[22] while blindness in premature babies is observed due to mi-
crophthalmia and cataract formation [23]. Few neonatal structural 
eye defects (ocular) such as loss of  neurons in the retinal gangli-
on cell (RGC) layer, optic nerve hypoplasia, dysmyelination, and 
disturbance in retinal cell morphology are generated due to fetal 
alcohol syndrome [24]. Retinal degeneration is another example 
of  eye related illnesses that imposes severe retinal edema with 
subretinal fluid bilateral congenital anophthalmia [25] (Figure 
2). New borns and infants also develop serious life-threatening 
complications due to an accidental brain injury [26]. These lead 
to visual impairments like degeneration of  optic nerve and lack 
of  coordination with central nervous system. Glaucoma results 
due to increased intra-ocular pressure generated after optic nerve 
degeneration. Optic nerve injury occurred due to severe trauma 
and disruption of  vascular supply after physical injury results in 
vision loss. Dry eye and limbal stem cell deficiency are serious op-
tic disorders. Corneal blindness is a visual defect which is found 
globally (Table 1). 
Major Reasons
Chromosomal aberrations, environmental stress and prenatal 
drug exposure are the most common causes of  neonatal eye de-
fects. Eye defects throughout the world result due to high blood 
pressure, radiation from screen, temperature, dust, heat and hu-
midity. Many people (particularly children) in developing and un-
derdeveloped countries, suffer from undernutrition and insuffi-
cient intake of  protein and thus face deficiencies of  vitamins and 
minerals, particularly iodine, iron, vitamin A and zinc. These de-
ficiencies are responsible for raising the risk of  chronic diseases, 
such as eye defects, heart disease and cancers. Genetics also play a 
decisive role in attributing eye defects including life style changes, 
domestic and cultural environment. In addition, physical influenc-
es such as global warming and ultraviolet radiation (UVR) severly 
affect functions of  eye and impose blindness mainly cataract and 
trachoma which are two of  the commonest causes of  the world 
blindness. Trachoma infection causes blindness and changes pa-
tient's behaviour. Another major reason of  rapid progression of  
cataract is ozone layer depletion and greater solar UVR receding 
on earth and rising global warming. There are many physical and 
biological causes of  cataract formation but high UV radiation is a 
major attributable cause. However, this can be rectified by cataract 
surgery. Glaucoma is almost certainly now the second cause of  
worldwide blindness (approximately 14.5%). Both primary open-
angle glaucoma (POAG) and primary angle closure is heritable. 
Nevertheless, there are important environmental risk factors to 
be confirmed (Figure 3).
Most of  the neonatal eye defects are induced in mother’s due 
to administration of  heavy drug dosage during pregnancy. Most 
suscetptible class that shows very high risk of  visual problems, 
are neonates exposed to opiates (methadone) and/or benzodiaz-
epines in utero [27]. Prolonged exposure of  ultraviolet radiation 
(UVR) from sunlight and therapeutic sources causes ocular tissue 
damage mainly in corneal surface to the retina. UV radiation also 
distroys stem cells found on anterior ocular surface and the lim-
bus [28] (Figure 3). Post birth apoptosis occurs in differentiating 
epithelium leading to the damage of  the entire eye [29]. Similarly, 
congenital virus infections caused by cytomegalovirus (CMV) and 
rubella virus infection [30] is a major cause of  birth defects found 
in early age children [31]. Retinal hemorrhage is also found in 
infants due to virus infection and is most commonly found in 
newborns [2]. Over dosage of  drugs and nutrition cause visual 
impairments in premature infants which are life-threatening [32]. 
Ethanol reacts with fetal membrane; causes cell lysis, suppress cell 
proliferation, and induce apoptosis. Ethanol exposure disturbs 
differentiation of  stem cells and expression of  corneal epithelial 
Figure 3. Showing various neonatal eye diseases caused due to environmental stress and action of  different carcinogens.
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cell-specific markers. Ethanol induces expression of  proinflam-
matory cytokines and chemokines in corneal epithelial and stro-
mal cells [34]. Cystinosis is caused by a deficiency in the lysosomal 
cystine transporter the cystinosin (CTNS gene) that results in cys-
tine crystal accumulation in tissues mainly in cornea.
As no proven treatment exists for inherited eye defects and only 
causal effects can be treated/improved by adopting different ther-
apeutic measures. But to avoid lifelong risks an essential ophthal-
mic examination of  neonates should be done by expert pediatri-
cians for early identification of  ophthalmic problems. Neonates 
should pass through red reflex screening test before being dis-
charged from hospital and after attaining an age of  6 weeks [34]. 
It will lower down the risks related to behavioral abnormalities 
[35] but sometimes early diagnosis may put critical impact on the 
prognosis for many ocular conditions, including potentially blind-
ing but cureable defects like congenital cataracts, life-threatening 
malignancies such as retinoblastoma and harbingers of  disease 
[36]. After seeing the occurrence of  sight related disabilities and 
dysfunctional ophthalmic tissues there is an immense need of  
neonatal diagnosis to reduce the chances of  such problems [4]. 
There must be an authentic diagnosis based on appropriate and 
potential biomarkers to treat the neonatal patients having eye de-
fects [37]. In addition, an earlier red reflex screening and physical 
examination of  newborns can short out ophthalmologic abnor-
mality that can reduce mental stress and pain [38]. 
Development of  eye and visual receptors
Eyes are photoreceptors possess visual pigments which actually 
provide the basis of  photochemical sensation. Eye possesses 
many vital components which assist to make vision more clear 
and objects visible. Eye is developed from a pair of  optic vesi-
cles situated on each side of  forebrain at the end of  4th week of  
pregnancy. Optic vesciles occur as outgrowths of  the brain which 
make contact with the surface ectoderm from various tissues are 
derived from three sources i.e. from neuroepithelium, surface ec-
toderm, and the extracellular mesenchyme which consists of  neu-
ral crest and mesoderm. Eye components are formed from the 
wall of  diencephalon (neural ectoderm), the superficial ectoderm 
(epidermal ectoderm), and the mesenchyme (mesoderm) of  the 
head. During its morphogenesis, each of  its components parts 
passes through the phase of  induction, and rudiments formation. 
Its important phases are development, differentiation and growth. 
Neuroepithelium forms the retina, cilliary body, iris, and optic 
nerve while extracellular mesenchyme forms the sclera, cornea, 
blood vessels, muscles, and vitreous. Few important components 
lens, corneal epithelium and eyelid are also formed. The mam-
malian eye possess three main layers i.e. the fibrous tunic is the 
outer layer of  the eyeball and consists of  cornea and sclera, sec-
ond middle vascularized or vascular tunic includes the iris, ciliary 
body and choroid. The choroid contains blood vessels that supply 
the retinal cells with necessary oxygen and remove the waste of  
respiration. The inner sensory layer includes the retina. Contribut-
ing to vision, the retina contains the photosensitive rod and cone 
cells and associated neurons. There is an enlarged entire cohort 
of  14 transcription factors that are required for eye development.
Eye development is initiated by the master control gene Pax-6, a 
homeobox gene known as Andridia in humans. The Pax-6 gene 
locus is a transcription factor for the various genes and growth 
factors involved in eye formation. Hmx1 is a homeodomain tran-
scription factor that is expressed in the developing eye mainly in 
peripheral ganglia, and branchial arches of  avian and mammalian 
embryos. Different expression patterns of  transcription factors 
and biological signaling are essential step for eye morphogene-
sis and differentiation. The pattern of  expression of  genes and 
transcription factor regulate eye development, proliferation and 
differentiation of  the neuroretina from progenitor cells. These 
mitotic progenitor cells appear to have the potential to form any 
of  the six major classes of  mature neurons i.e. photoreceptors, 
bipolar, horizontal, interplexiform, amacrine and ganglion cells, 
as well as Müller cells, a type of  glial cell. 
The eye morphogenesis starts as an out growth (evagination) of  
the optic grooves which transform into optic vesicle. The op-
tic vesicles then develop into the optic cup with the inner layer 
forming the retina and the outer portion forming the retinal pig-
ment epithelium. The hemispheric, bi-layered optic cup is formed 
from an oval optic vesicle during early vertebrate eye develop-
ment through major morphological transformations. The middle 
portion of  the optic cup develops into the ciliary body and iris. 
The prospective neurosecretory retinal layer of  optic vesicle in-
ducts the epidermis of  head, opposite to the optic vesicles, which 
thicken to form the lens placodes. The placode of  the each side 
invaginate to form the lens cup which gradually deepens and pro-
gressively pinched off  from the epidermis, until it form the closed 
lens vesicles. The component of  cornea shows tensile strength 
and regenerative properties. It displays characteristic interference 
pattern in polarized light using an appropriate refractive index and 
a controlled curvature that contributes to its refractory powers 
and transparency. 
The multipotent neuroretinal progenitor cells of  the optic cup 
continue to proliferate and differentiate into mature retinal neu-
rons. The commitment of  a competent post-mitotic retinal pro-
genitor cell to a specific cell fate is controlled by signals from 
the microenvironment. Thus, transcription factors may make 
post-mitotic retinal cells competent to respond to appropriate 
environmental stimuli, and initiate the production of  signals by 
the cell that modify the microenvironment, thereby influencing 
the developmental program of  neighbouring cells. Therefore, in 
a particular environment, the combination of  transcription fac-
tors expressed by a cell can be regarded as its ‘transcription factor 
code’. Further differentiation and mechanical rearrangement of  
cells in and around the optic cup gives rise to the fully developed 
eye.
Eye structure and its components
Eye of  vertebrates possesses a fluid filled globular sac like struc-
ture called eye ball. It is structurally complex contains three con-
centric tunics i.e. fibrous, vascular and neurosensory tunics. Fi-
brous tunic protects the eye ball that is transparent and forming 
the cornea. Over the rest of  the eye ball it is opaque and called 
sclerotic coat. The circular line between cornea and sclera is called 
sclero corneal junction. Histologically, sclera consists of  interlac-
ing collagen fibers. In cornea, the collagen fibers are partially ar-
ranged in bundles. The external corneal surface is thin and trans-
parent corneal epithelium. The vascular tunic is thinner, middle 
layer of  eye ball consists of  three parts i.e. choroid, ciliary body 
and iris. The large central aperture of  iris is called pupil. The third 
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coat neurosensory tunic is retina that is innermost, thinnest and 
softest. The retina is the neurological tissue that lines the inner 
surface of  the eyeball at the back of  the eyeball. Retina possess 
two main layers an outer simple epithelium of  cuboidal cells that 
are heavily pigmented and an inner layer. It is also a simple cuboi-
dal epithelium in ciliary and iris parts of  retina but in optic region 
it is thick and highly complex, containing light sensitive elements, 
nerve cells and fibres. It consists of  three layers an outer layer 
of  rods and cone cells, middle layer of  bipolar nerve cells and 
inner layer of  ganglionic nerve cells. The layer of  rods and cones 
consists of  highly specialized neurosensory cells which are actual 
light sensitive cells. The cells of  pigment epithelium bear abun-
dant microvilii extending in between the rods and cones. The rods 
are longer, slender and cylndirical. Rods out number cones and 
perceive light in dim light conditions while cones perceive colours 
in bright light. Cones are shorter, thicker and club shaped. Each 
retinal cell has a nucleated cell body and a photosensitive outer 
segment resting upon the pigmented epithelium and an inner seg-
ment between these two. Neuronal elements of  retina are bound 
together by supporting glial cells called Mullar cells. Pigments 
found in photoreceptors include retinal (retinylidene proteins) for 
example rhodopsin in animals). The retina is an area on the back 
of  the eye. Light falls on the retina and on the rods and cones that 
are on the retina. These convert light input into visual images in 
our mind. Rods contain a higher amount of  photopigments and 
are more sensitive to light than cones, which make the rods useful 
for seeing at night or in dim conditions. 
There are ten retinal layers; the two layers that pertain to the rods 
and cones are the outer nuclear layer, containing the rod and cone 
inner segments, and the photoreceptor layer, where the outer seg-
ments of  the rods and cones are located. The inner segment of  
the rods and cones contain the cell's nucleus, mitochondria, Golgi 
apparatus, and all of  the other elements of  the cell that allow it 
to functions properly. The outer segments of  the rods and cones 
contain a protein known as opsin. Retinal is a specific portion 
of  the opsin protein that is affected by light. When a particle of  
light comes into contact with the retinal portion of  the opsin, 
the retinal undergoes a chemical change. Rods are designed to be 
stimulated more easily by smaller amounts of  light. However, they 
lack the ability to detect color differences or to see in fine detail. 
Rods function better in the dark for detecting movement. The 
cone cells are much smaller and are responsible for providing fine 
detail and color vision.
Therapeutics for neonatal diseases
Stem cell cultures are used to seek new, healthy specialized cells 
that can be used to replace damaged cells in the eye. Stem cell 
transplants are potentially used to treat various eye-specific pa-
thologies mainly to replace defective retinal ganglion cells and 
photoreceptors cornea or lens [39] (Figure 4). There are several 
categories of  stem cells which are used in different ways, to treat 
neonatal eye disorders. Autologous stem cells are used in person-
alized regenerative medicine mainly for treatment of  ocular sur-
face diseases by using selective tissue grafts for transplantation of  
the corneal surface layers (Figure 4). Healthy retinal cells can be 
derived from human embryonic stem cells (hESCs) for treatment 
of  retinitis under defined culture conditions for the same. But 
neural impairments related to vision loss are most challenging to 
treat because neurons do not under go regeneration and microglia 
transplantaions are impossible to done. 
Cornea is the transparent front part of  the eye whose transpar-
ency depends on a unique extracellular matrix secreted by stromal 
keratocytes and mesenchymal cells of  neural crest lineage [40]. 
The cornea is covered by a stratified epithelium that contains 
stem cells which form limbus. Corneal transparency in various 
animal eyes is maintained by enzymatic crystallins. It is the most 
anterior segment of  the eye that provides exquisite vision. It acts 
as a major protective shield to the eye and represents two thirds 
of  its refractive power. It is made up of  three distinct cell layers of  
different developmental origins: the outer, epithelial layer devel-
ops from the ectoderm overlying the lens vesicle; whereas iter, the 
stroma and the endothelium have mesenchymal origin. Its stromal 
cell layer is self-renewing epithelium that contains resident stem 
cell population. The cornea is derived from ectodermal/neural 
crest cells and formed through a cascade of  molecular mecha-
nisms which provides it specific optical features which are neces-
sary for refractory function. Cornea is the transparent exposed 
portion of  the tunic which focuses light in the eye. It is an impor-
tant visual structure that is needed for a clear vision by refracting 
light onto the lens, which in turn focusing on the retina. It is a vital 
tissue that remains poorly protected from the environment and 
face toxic dust and heat exposure. Corneal limbal defects related 
to opacity and neovascularization can be restored by using epithe-
lial stem cells reside in limbal stroma and the corneal-endothelium 
[41]. Moreover, during cornea formation and maturation, large 
population of  epithelial stem cells is sequestered towards the local 
sites for providing a long lasting source for renewal in the adult 
[42]. Corneal cells are highly sensitive to heat, light and tempera-
ture, these remain constantly damaged and replaced by new cells.
Figure 4. Showing use of  stem cell therapy, scaffolds and biomatrixes for regeneration of  visual tissues.
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In a normal functional eye damaged cells or aging epithelial cells 
(epithelium) are continuously replaced by population of  stem 
cells (SC) throughout life. A small population of  limbal stem cells 
found at the edge of  the cornea, which easily replace damaged 
cells, and repair physically injured part. Once these cells lost due 
to injury or disease, the cornea can no longer be repaired. A per-
manent injury in cornea may affect the ability of  light to enter 
the eye, and results in a significant loss of  vision. Natural corneal 
defects appeared as a bilateral disorder known as limbal stem cell 
(LSC) deficiency that can be cured [43] by using autologous LSCs 
(Limbal stem cells) transplantation [44]. But to procure autolo-
gous corneal stem cells is not possible in patients facing bilateral 
limbal stem cell deficiency (LSCD). However, limbal stem cell tis-
sues obtained from healthy eye can repair the cornea and give 
the patient to restore their vision. Though it is a cumbersome 
job to find donors and assure compatibility of  stem cells with 
the cornea. In extreme cases of  patient damaging his both eyes, 
it may not be possible to obtain any limbal stem cells. But stem 
cells found in the optic nerve of  many animals can overcome this 
problem. CNS stem cells are inhibited and remain dormant after 
injury. Injecting stem cells into damaged spinal nerve tracts can 
rejuvenate spinal cord in man. 
Failures of  corneal epithelial stem cell transplatation can result 
in painful and blinding disease of  the ocular surface [45]. Mainly 
corneal epithelium or corneal epithelial layer get injured due to 
severe environmental stress mainly heat, light and high thermal 
temperature. All these factors results in dysfunction of  trans-
planted cells and leads to reduction of  visual clarity and loss of  
vision. These corneal epithelial injuries can be repaired by using 
limbal stem cells but it is very slow in diabetic patients. In case of  
extensive chemical burns or physically injured corneas only cure 
is limbal stem cell deficiency [46]. However, for corneal epithelial 
cell renewal and wound healing appropriate integration and coor-
dination of  cell signaling events are highly needful. In such cases, 
treatment may involve transfer of  growth factor and normal adult 
stem cells to the ocular surface [47] (Figure 4). Topical tacroli-
mus treatment also cause significant decrease in corneal vascu-
larization and reduce cellular inflammation in cells [48]. Similarly, 
insulin-like growth factor 1 (IGF-1) are also used to form three-
dimensional ocular-like structures from human embryonic stem 
cells (hESCs) [49]. The transformation of  the oval optic vesicle to 
a hemispheric bi-layered optic cup involves major morphological 
changes during early vertebrate eye development [50]. 
Cornea is a highly organized, transparent connective tissue that 
is maintained by keratocytes. These cells are quiescent mesen-
chymal cells of  neural crest origin. A small population of  cells 
in the mammalian stroma displays properties of  mesenchymal 
stem cells, including clonal growth, multipotent differentiation, 
and expression of  an array of  stem cell-specific markers. In cell 
culture medium corneal stromal stem cells (CSSCs) undergo ex-
tensive expansion without loss of  the ability to adopt a keratocyte 
phenotype [51]. The corneal stroma is large repository for stem 
cells but peripheral cornea and limbus are also good sites. These 
peripheral and limbal corneal stromal cells (PLCSCs) are known 
to produce mesenchymal stem cells in vitro. Both corneal stromal 
and epithelial progenitor show transdifferentiation ability [52] and 
can be used for the treatment of  many systemic lysosomal stor-
age disorders [53]. For derivation and formation of  various cell 
types from progenitor or stem cell of  the keratocyte maintaince 
of  niches is highly required. It also plays an important role in cor-
neal regeneration [54]. Topical administration of  eye drops is the 
major route for drug delivery to the cornea. It is extensively used 
in alkali-induced corneal wound [55]. Topical OFSC (orbital fat 
derived stem cells) administration is provided to promote corneal 
tissue regeneration through ameliorating acute inflammation and 
corneal epithelial differentiation. For repairing of  neonatal eye 
defects and regeneration of  visual tissues scaffolds, biomatrixes 
and stem cell therapy are important tools [55] (Figure 4). 
 
Emulatiion of  corneal stromal tissue is most challenging task in 
bioengineering to have artificial human cornea. It is very diffi-
cult to reproduce highly ordered microstructure, with all biome-
chanical properties and optical transparency of  this tissue [56]. 
Therefore, both human corneal stromal stem cells (hCSSCs) and 
RGD surface-coupled patterned silk film are used to develop 
highly ordered collagen fibril-based constructs for corneal regen-
eration and corneal stromal tissue repair [56]. From human em-
bryonic stem cells (hESCs), corneal endothelial cells (CECs) can 
be derived similar to native human CECs [57]. These cells have 
potential application in replacement therapies as substitution for 
donor CECs [59]. Cultured human CECs show stem cell markers 
including nestin, OCT3/4, and GFAP which differ according to 
the culture media and associated proliferation rate [58]. Mouse 
adipose tissue mesothelial cells (ATMCs) show similar morpho-
logic and biochemical characteristics with mouse (CECs). These 
show capacity to adhere to the decellularized basal membrane of  
human anterior lens capsules (HALCs) and are used as potential 
tissue-engineered source for corneal endothelium replacement 
[59] (Figure 5). 
Corneal transplantation is best therapetics for severe corneal dis-
orders. It is the primary treatment option to restore vision for pa-
tients with corneal endothelial blindness. For transplantation pur-
pose tissue-engineered corneal endothelial grafts are constructed 
by using cultivated human corneal endothelial cells. These can be 
isolated from cadaveric corneas and may serve as a potential graft 
source [60]. Similarly, transplantation of  human umbilical mes-
enchymal stem cells is found successful to repair corneal defects 
in mice [61]. TECE (Tissue-engineered corneal endothelium) 
transplantation aids in corneal transparency and thickness, while 
stem cell therapy can restore corneal endothelial dysfunctions [62]
(Figure 5). Patients with advanced corneal disease show very poor 
conventional corneal transplantation success and need kerato-
prosthesis (KPro) for visual rehabilitation. For construction of  
KPro is poly(methyl methacrylate) (PMMA) is used in central op-
tical core and a donor cornea as skirt material [63] . 
 
Human corneal endothelial cells (HCECs) shows limited prolif-
erative ability in vitro. However, for the cultivating HCECs, condi-
tioned medium (CM) is obtained from human bone marrow-de-
rived mesenchymal stem cells (MSCs) (MSC-CM) for consistent 
expansion of  HCECs. Interactions between stromal and epithelial 
cells play important roles in the development, homeostasis, and 
pathological conditions of  the cornea. These interactions need 
number of  soluble as critical factors and growth factors which are 
secreted from corneal stromal cells and contribute to the regula-
tion of  proliferation and differentiation of  corneal epithelial cells 
(CECs) [64]. Basal layer of  corneal epithelium can repair epithelial 
cell damage but these could not regenerate in vivo. More-excep-
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tionally stem cells found in basal layer convert into endothelial 
cells under certain circumstances. Both stromal cells and epithe-
lial cells may act in concert in the cornea [64]. Stromal stem cells 
show biocompatibility in grafts and make sheets of  decellularized 
human corneal stroma with or without the recellularization [65]. 
Another emerging therapeutic strategy consists of  obtaining and 
implementing human progenitor cells of  different origins using 
tissue engineering methods (Figure 4). 
 
Human neural crest cells (hNCCs) derived from human pluripo-
tent stem cells (hPSCs) are embryonic migratory cell population. 
These cells showed the ability to differentiate into a wide variety 
of  cell types [66] and also exhibit neurogenic potential [67]. Simi-
larly, adipose-derived mesenchymal stem cells (ADMSCs) differ-
entiate into corneal epithelium-like cells after transfection with 
Pax6 gene [39]. These cells are good source of  generating corneal 
epithelium- for construction of  tissue engineered cornea. Corneal 
stroma contains stem cell population which are heterogeneous 
in nature and show similarity with neural crest progenitor cells. 
These cells are also used for surgical treatment of  fungal kera-
titis [68]. More specifically, visual cells and retina are formed by 
an ancestral neural circuit that works under a conserved network 
of  genes (including Pax6/eyeless) [69]. These genes create differ-
ences in morphology and structure of  photoreceptor-type usage 
and lens. Human adipose-derived cells (hASCs) found overlaid on 
scleral contact lens (SCL) act as carrier and prolieferate to finish 
ocular alkaline burn [70] (Figure 5).
Restoration of  vision
Keratocytes derived from human embryonic stem (hES) cells are 
used in cell-based therapy mainly for removal of  corneal blind-
ness. Mainly human fetal keratocytes (HFKs) start differentiation 
into neural crest-derived tissues when challenged in an embryonic 
environment [71]. These cells are maintained and expanded in 
feeder-free culture medium. These cells differentiate into neural 
crest cells by using the stromal-derived inducing activity of  the 
PA6 mouse embryonic fibroblast cell line [72] (Figuer 5). Kerato-
cytes are potentially used for restoration of  vision and have en-
larged biomedical engineering applications. But these specialized 
cells can not readily expand in vitro. Though culturing corneal 
keratocytes is very difficult because keratocytes growing in a mon-
olayer rapidly lose their stellate morphology and cease to express 
keratocyte markers such as keratocan, lumican and aldehyde dehy-
drogenase 1 family, member A1 (ALDH1A1) [41]. Similarly, stem 
cells found in corneal limbal region need specific microniche [41].
Dental pulp contains a population of  adult stem cells much simi-
lar to corneal stroma. These cells develop embryonically from the 
cranial neural crest. Morever, adult dental pulp cells (DPCs) iso-
lated from third molars showed the capability to differentiate into 
keratocytes, cells of  the corneal stoma. After inducing differentia-
tion in vitro, DPCs express molecules characteristic of  keratocytes, 
keratocan, and keratan sulfate proteoglycans at both the gene and 
the protein levels. DPCs that are cultured on aligned nanofiber 
substrates are used to make corneal stromal-like constructs mainly 
tightly packed, aligned, parallel fibrillar collagen of  native stromal 
tissue. Keratocytes derived from DPCs can be used for clinical ap-
plication mainly in cellular or tissue engineering therapies for cor-
neal stromal blindness [73]. During stromal healing, keratocytes 
get transformed to motile and contractile myofibroblasts largely 
due to activation of  transforming growth factor-β (TGF-β) sys-
tem. Keratoconjunctivitis sicca or dry eye disease is an immune-
mediated multifactorial disease largely found in humans and dogs 
[74]. Figure 5 illustrates stem cells derived nerve cells for retinal 
replacement.
Corneal wound healing
Corneal wound healing is a complex process involving cell death, 
migration, proliferation and, differentiation. It also needs extra-
cellular matrix remodeling. Many similarities are observed in the 
healing processes of  corneal epithelial, stromal and endothelial 
cells, as well as cell-specific differences. Corneal epithelial healing 
largely depends on limbal stem cells and remodeling of  the base-
ment membrane. Improved methods are developed for growing 
limbal stem cells in the laboratories which are becoming highly 
feasible biomaterials for better transplantation. However, to over-
come the scarcity of  stem cells new potential sources of  stem cell 
derivation have been searched. In the laboratory limbal stem cells 
can be derived from embryonic stem cells or induced pluripotent 
stem (iPS) cells. These are used as endless source for generating 
large quantities of  limbal stem cells for therapeutics of  patients 
mainly those who want to avoid surgical operation and are in great 
need (Figure 5). 
The mammalian cornea contains a population of  basal epithelial 
stem cells which maintain homeostasis and continue repairing. 
Corneal stem cells are used to generate corneal cells for long term 
supply of  source material [75]. These cells transform to precursor 
Figure 5. Stem cell derived nerve cells are used for the replacement of  defective retinal cells.
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cells (epithelial cells) in spheroid cell culture [76] and develop in to 
keratocytes [80]. These cells also participate in corneal regenera-
tion [77]. Besides, conventional allograft therapy, corneal scarring 
method is also developed to avoid allograft rejection and to reduce 
complications related to endothelial failure. In explants culture, 
stromal cells are used as autofeeder layer and expansion of  human 
corneal epithelial cells [78]. However, for deriving limbal epithe-
lial stem cells for healing purpose, a micro niche is needed for 
self-renewal of  the corneal epithelial stem cells through out life. 
In addition, few growth factors, stromal niche cells, and specific 
extracellular matrix compositions are also required to maintain 
this environment [79]. Moreover, cultured corneal epithelial cells 
are considered to be promising material for constructing bioarti-
ficial cornea [80]. Similarly, mesenchymal stem cells (MSCs) ac-
quire certain characteristics of  corneal epithelial cells [81]. These 
cells are isolated from noncorneal tissues for stem cell therapies 
of  cornea. These cells show immuno-modulatory properties, and 
claims to transdifferentiation into corneal cells [82] (Figure 5). 
Corneal endothelial dysfunction is a major problem in corneal 
transplantation. Similarly, endothelial cells healing needs migra-
tion and spreading of  cells after proliferation [83]. However, 
HCECs (human corneal epitheial cells) cultured on the PCM-DM 
provides a feasible xeno-free matrix substrate is used in tissue-
engineered based therapy of  corneal endothelial dysfunction 
[84]. Therefore for therapeutic long ex vivo culture is needed to 
generate enough cell numbers for transplantation [85]. Limbal 
biopsy-derived stromal cells (LBSCs) expanded rapidly in media 
containing human serum that are highly clonogenic. These could 
generate spheres expressing stem cell genes (ABCG2, Nestin, 
NGFR, Oct4, PAX6, and Sox2) [86]. These LBSCs (limbal bi-
opsy-derived stromal cells) are capable of  corneal stromal regen-
eration and can be used as potential source for autologous stem 
cells for treatment of  corneal stromal blindness [86]. Allogeneic 
limbal mesenchymal stem cell (LMSC) therapy is used for corneal 
healing after a severe chemical burn, but route of  administration 
of  LMSCs differs in its therapeutic effect [87]. However, direct 
treatment of  corneal scarring can be done by using autologous 
stem cells that can reduce the need for corneal grafts (Figure 5). 
Healthy corneal endothelium maintains corneal clarity. Once cor-
neal endothelium get damaged and loss of  cell count ocuurs it 
results in severe visual impairment. For this purpose barrier and 
pump functions are essentially normalized for the maintenance 
of  corneal transparency and restoration of  corneal endothelial 
dysfunction [88]. However, to maintain a smooth optical surface, 
corneal epithelium should be continuously renewed to function 
as a barrier so that it could protect the eye from various envi-
ronmental insults. Further, adult corneal epithelium is normally 
maintained homeostatically by an integrated process of  cell pro-
liferation, migration, differentiation, stratification, and desqua-
mation/apoptosis. Failure of  endothmation results in persistent 
corneal defect that leads to the blindness. Some times ocular sur-
face defects also cause vision impairment or even total blindness. 
However, to restore the ocular surface in patients, autologous ex-
traocular stem cells are used to avoid host immunosuppression 
of  allogenic transplants. Human adult mesenchymal stromal cells, 
represents a significant breakthrough in the treatment of  certain 
eye diseases. These are less invasive and more feasible for ocular 
surface regeneration [89] (Figure 5).
Regeneration of  eye components
Corneal epithelium contains a population of  progenitor cells 
which contineously repair cornea and restore its normal function 
byself  renewal. However, cellular integrity of  corneal epithelium 
maintains cornea's transparency and vision. Currently, cell-based 
therapies are used in replacement of  defective eye components 
mainly for restoration of  visual receptors. These are also used for 
treating limbal stem cell deficiencies. For this purpose both cul-
tured limbal epithelial transplantation and cultured oral mucosal 
epithelial transplantations are done. Besides this, sphere-forming 
cells are generated from peripheral corneal stem cells. These are 
used as potential source of  progenitor cells for treatment of  cor-
neal degenerative diseases [90]. Normally, stratified multilayered 
collagen fibril lamellae with orthogonal orientation determine the 
robust biomechanical properties of  corneal tissue but to creat 
uniform collagen fibril size and interfibrillar spacing are very criti-
cal to maintain optical transparency [91]. Moreover, recapitulating 
the microstructure of  the native human corneal stromal tissue 
is key success in engineering the corneal tissue. But recapitula-
tion of  human corneal stromal tissue is a most challenging step 
in engineering human corneal tissue because of  the difficulty in 
reproducing its highly-ordered hierarchical ultrastructure to gen-
erate required optical transparency [92] (Figure 5). 
Among different possible reasons of  congenital human cataracts 
point mutations in the alphaA-crystallin gene are main architects 
[93]. AlphaA-crystallin (Cryaa/HSPB4) is a small heat shock pro-
tein and molecular chaperone that prevents nonspecific aggrega-
tion of  denaturing proteins. Instead DrGRIFIN protein belongs 
to galectin family member function as a crystalline material and 
show carbohydrate-binding properties [94]. Similarly, Eph recep-
tor tyrosine kinases and their ligands such as ephrins, regulate the 
development and maintenance of  normal corneal architecture 
[95]. Therefore, an early diagnosis and appropriate therapy be 
needed because p63 gene mutations have a critical role in main-
taining the integrity of  the ocular surface in the setting of  limbal 
stem cell deficiency. There are other reasons of  ocular surface 
problems such as lid disease, meibomian gland dysfunction and 
toxicity from topical medications. Therefore, patients should keep 
under regular monitoring at frequent intervals to avoid adverse 
secondary effects of  all different medications provided [17] (Fig-
ure 5).
Restoration of  retinal pigment epithelial cells
Retina is pigmented component of  the eye which detects light, 
once damages; it leads to the onset of  blindness. Number of  
methods are available which are potentially used to restore physi-
ological functions of  pigmented retinal epithelial cells. These cells 
perform a number of  important functions to adjacent retina but 
with the age macular degeneration (AMD), retinitis pigmentosa 
and Leber’s congenital aneurosis abnormalities occurred. Upon 
injury retinal epithelial cells stop working properly and also af-
fect retinal function. However, for treatment of  such retinal dis-
orders/diseases can be done by replacing the damaged RPE cells 
with transplanted healthy cells. For transplantation purpose RPE 
cells can be derived from both embryonic stem cells and induced 
pluripotent cells in the laboratory. Such experiments never be-
come successful in case of  complete damage, and RPE cell re-
placment found effective only in least working retina, or level 
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of  vision restored at early stages of  the disease. Unlike RPE cell 
transplantation, direct repair of  the retina is also possible those 
who have already lost their vision. However, cell transplantation 
gives hope to the patients with macular degeneration, and fac-
ing loss of  light-sensitive photoreceptor cells in the retina. Other 
defects are malfunctioning of  retinal circuits which stop working 
properly or die off. Such types of  restorations of  retinal cells be-
come possible only after activating the optic nerve. 
By using stem cell technology different types of  retinal cells can 
be derived for replacement therapy to treat retinal diseases like 
retinitis pigmentosa and glaucoma. Similar retinal stem cells have 
bee obtained from ciliary epithelium found at the retinal margin 
of  the adult mouse and human eyes. These cells divide in vitro in 
the absence of  growth factors to generate clonal, self-renewing 
spheres which can generate all the retinal cell types. But various 
factors which impose anti-proliferative effects on RSCs (Rare 
retinal stem cells) are secreted by the adult lens and cornea which 
obstruct the proliferation of  RSCs in vitro. Few important prin-
cipal factors which show anti-proliferative effects are bone mor-
phogenetic protein (BMP)2, BMP4, and secreted frizzled related 
protein [96]. The retinal pigment epithelium (RPE) is a monolayer 
of  cells that found underlying neural retina [97]. It proliferates to 
form a plastic tissue, capable of  generating lens and retina, but 
during early development its remains normally non-proliferative 
throughout life [98]. Similarly in vitro regeneration of  optic nerve 
damage is possible by using certain growth factors. In animals it 
may assist in regaining the ability to detect overall movement of  
the visual field and were able to perceive light.
Lens regeneration
Lens is situated in the interior of  the eye, just behind the iris. 
It is clear, crystalline and glassy in appearance and biconvex in 
form. Lens is formed from a single progenitor cell lineage after 
multiple states of  differentiation. Lens opacity is disturbed due 
to protein aggregation that generates cataract. Lens regeneration 
occurs in newts for repairing of  lost tissue [99]. Defective tis-
sue is replaced by transdifferentiation of  cornea epithelial cells 
[100] in presence of  epithelium-derived growth factor (LEDGF/
p75). It is is a transcription co-activator that shows epithelial cell 
gene regulation and evoke stress responses. The Drosophila eye-
less gene plays a central role in fly eye development. This gene 
controls a subordinate regulatory network consisting of  eya and 
dac genes [101]. Similarly, LEDGF/p75factor plays an important 
role in lens epithelial to fibre cell terminal differentiation [102]. Id 
or msh gene expression regulators are required for limbo-corneal 
and conjunctival [103]. Three different FGF receptor (Figure 1, 
Figure 2, Figure 3) participate in developing less. These genes in-
duce differentiation of  lens epithelial cells into fiber cells both in 
vitro and in vivo. Fggire1 plays an independent, essential role in lens 
development [104] (Table 2). 
An initial event that triggers eye morphogenesis is physical con-
tact of  optic vesicle with head surface ectoderm. This important 
interaction leads to lens specification followed by coordinated in-
vagination of  the lens placode and optic vesicle, resulting in for-
mation of  the lens, retina and retinal pigmented epithelium [92]. 
Cell specific culture systems have been developed to generate eye-
like structures mainly related with lens, neural retina, and retinal 
pigmented epithelium (RPE) cells from undifferentiated embry-
onic stem cells. These RPE-like cells transform into in eye-like 
structures when transplanted these form neuronal retina [105]. 
Many ocular diseases, such as retinitis pigmentosa and age-relat-
ed macular degeneration, caused due to damage of  specific cells 
which can not be normally repaired or replaced. For treatment of  
these degenerative diseases transplantation of  healthy fetal cells 
from a suitable donor remains workable [106]. 
Lens and retina of  eye are also formed from transdifferentiation 
of  stem cells [107]. Similarly, lens regeneration occurs by pro-
cesses of  both cellular dedifferentiation and transdifferentiation 
that also generate other cell types [108]. In vertebrates eye tis-
sue regeneration also occurs after transdifferentiation of  one cell 
type to another. Transdifferentiation belongs to a wider class of  
cell type transformations called metaplasias which also includes 
cases in which stem cells of  one tissue type switch to a com-
pletely different stem cell. Similar transdifferentiation also occurs 
in functional organs such as tentacles, feeding organ (manubrium) 
and striated muscles of  jellyfish (Anthomedusae) in vitro [109]. 
Transdifferentiation starts after induction of  molecular and cellu-
lar mechanisms that underlie the switches in phenotype, together 
with their significance to organogenesis and regenerative medi-
cine. Lens regeneration in newts proceeds from the dorsal margin 
of  the iris where pigment epithelial cells (PEC) re-enter the cell 
cycle and transdifferentiate into lens [110]. This is the the main 
reason that adult newts are able to regenerate their retina and lens 
after injury or can do complete removal through transdifferentia-
tion of  the pigmented epithelial tissues of  the eye [111]. 
Epitheial cells found in anterior portion of  the lens capsule show 
pluripotency, proliferation and migration potential. These are 
used for opacification after cataract surgery [52]. Besides transdif-
ferentiation, reprogramming of  pigmented epithelial cells (PECs) 
is also important process that involves in newt lens regeneration 
[112]. After lens removal, PECs in dorsal iris dedifferentiate and 
revert to stem cell-like cells, and transdifferentiate into lens cells. 
During this phase global histone modifications are needed for re-
programming of  PECs [112]. Human embryonic stem cells dif-
ferentiate into large quantities of  lens progenitor-like cells in new 
3-stage system and differentiated 3-dimensional lentoid bodies 
[113]. Inhibition of  BMP signaling by noggin triggers differentia-
tion of  hESCs toward neuroectoderm [113]. 
Two genes OCT4-pg1 retrogene and NANOG play important 
role in self-renewal and differentiation of  pluripotent cells in a 
developing eye [114] (Table 2). Normally, for stem cell mainte-
nance, cellular proliferation and differentiation Wnt-signaling 
pathway acts as an important regulator. It is also followed during 
cancer development in various tissues. Its normal function states 
retinal development while failure may states occurrence of  a dis-
ease [115]. A third gene Pitx3 maintains lens epithelial phenotype 
and prevents inappropriate fibre cell differentiation during lens 
development [116]. BetaB2-crystallin is not essentially required 
for the normal development of  a transparent lens in the mouse 
but it plays important role in maintaining the transparency of  the 
lens after birth. It interacts with other crystallins to increase their 
resistance to thermal denaturation and oxidative stress [117]. Lens 
crystallins are expressed in mammalian corneas and cultured cor-
neal cells [118] (Table 2). Germinative zone of  lens contains stem 
cells [119] which can form lens epithelium [120].
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Neurogenesis in outer neuroblast zone and the secondary lens fi-
bre formation takes place during 6th week of  development [121]. 
It also passes through cell proliferation and transdifferentiation 
of  lens epithelial cells (LECs). But its conversion to myofibro-
blasts results in secondary cataract formation. Neurogenesis show 
increased expression of  alpha-smooth muscle actin (alpha-SMA) 
that is influenced by other factors such as β-FGF, TGF-beta2, 
EGF and IGF-1 [122] (Table 2). In the adult organism, tissue 
renewal and regeneration depends ultimately on proliferation of  
somatic stem cells. Similar proliferation and differentiation is also 
required in eye tissues. Lens epithelial cells show slow cycling and 
possess ability to differentiate terminally into fiber cells. These 
can be obtained from stem cell lineage [123]. In this process tel-
omerase plays a protective in lens epithelial cells [124]. 
In defective photoreceptor cells like retina and lens re-activation 
of  many of  the genes is highly important. A similar environment 
be needed that is required during development of  the eye for cel-
lular differentiation and gene invoking. In anuran amphibians re-
generation of  the retina occurs through differentiation of  stem 
cells in the ciliary marginal zone and transdifferentiation of  the 
retinal pigmented epithelium [125]. Lens regeneration in adult 
newts occurs via transdifferentiation of  the pigment epithelial 
cells (PECs) of  the dorsal iris. Both up-regulation and down-reg-
ulation of  few genes also leads to dedifferentiation [126]. Moreo-
ver, during lens and limb regeneration in newts mammalian stem 
cell pluripotency-inducing factors are expressed. Further, during 
differentiation process stemness should maintain because a slight 
change in factors and environment may stop corneal epithelial, 
stromal and endothelial cell differentiation [127, 128].
Cataract in man is a complex disease that is caused due to effect 
of  genetic and environmental factors [113]. It happens due to 
exposure of  photoreceptors to strong light, physical stress, heat 
and sweating in high humidity and temperature. All these factors 
create defects in lens. Similarly congenital cataract also occurs in 
neonates during development period due to stress response and 
heat shock factors (HSFs). Environmental factors, drugs and 
physical stress play crucial roles in differentiation and develop-
ment of  lens. Heat shock transcription factor 4 (HSF4) deficien-
cies leads to defect in lens epithelial cell (LEC) due to obstruction 
of  differentiation [129]. Hence, proper differentiation of  both the 
corneal endothelium and the iris is required for development of  
tissues in the anterior chamber [130]. Similar cell proliferation is 
needed for formation of  optic cup, stalk, the cornea, and the lens.
Stromal keratocytes found in the stroma of  the limbus can be 
expanded in culture for obtaining limbal fibroblasts (LFs). These 
cells showed similar characteristics to bone marrow mesenchy-
mal stem cells (BM-MSCs) and are used to maintain the epithe-
lial stem cell phenotype in the limbal region. Limbal fibroblasts 
showed a greater potential for differentiation into corneal epithe-
lium. Similarly, tissue-specific adult progenitors which show re-
programming capacity can be used for obtaining desirable cells 
types for therapeutic purposes [128]. But it will need more favora-
ble environment for stage specific differentiation [128], otherwise 
there occurs a loss of  cell lineage that may form lens placode 
and any other tissue [131]. However, new simple, reproducible, 
animal-material free methods are used for cultivating and char-
acterizing cornea limbal epithelial stem cells (LESCs) on human 
lens capsule (LC) [132]. Both corneal epithelium and lens share a 
common pool of  precursors [133]. Increasing concentration of  
calcium and epidermal growth factors (EGF) aids in stem cell 
proliferation, regeneration and repair (Table 2). 
Pax6 is the universal gene that regulates eye morphogenesis. It is 
also expressed in the ocular surface epithelium from early gesta-
tion until the postnatal stage [134]. Similarly, Lim2 gene plays a 
critical role in establishing the correct internal refractive proper-
ties of  the crystalline lens [135] (Table 2). Stathmin a small cyto-
plasmic phosphoprotein is required for regeneration of  injured 
neural tissues in Japanese common newts (Cynops pyrrhogaster). 
It is a microtubule regulator [136]. Similarly, BMP signals (bone 
morphogenetic protein signals) are also required to induce olfac-
tory and lens placodal cells from progenitor cells found at the 
anterior neural plate border [137]. Ciliary body is a good source 
of  lens stem cells which are used for generation of  corneal epi-
thelium [138]. Human anterior lens capsule are used as a biologic 
substrate for the ex vivo expansion of  limbal stem cells in ocular 
surface reconstruction [106]. There are many ocular surface dis-
orders that are caused due to damage in the limbal region that 
results in destruction of  corneal stem cells. For lens regenera-
tion, induction of  transdifferentiation in pigment epithelial cells 
is highly needful in stem cells bioengineering [139]. Moreover, for 
treatment of  several ocular surface diseases limbal transplantation 
or cultivated limbal cell transplantation are usually done [140]. 
Other methods that are followed for control of  ocular disease and 
prenatal genetic eye related genetic disorders preclude ocular stem 
cell populations based lentiviral vector-based gene transfer [141]. 
More specifically, multipotent cells found within the iris pigment 
epithelium (IPE) [142] can be used for regeneration of  lens tissue 
in newts because of  their developmental plasticity. Similarly, neu-
ral retinal regeneration occurs in the anuran amphibian Xenopus 
laevis during post-metamorphosis follows transdifferentiation of  
retinal pigmented epithelium [143]. Moreoften, for cell replace-
ment therapy reprogramming of  cells from one tissue type to an-
other needs manipulation of  expression of  transcription factors. 
These reprogrammed cells [144] induced by certain transcription 
factors maintain apoptosis and may involve in the perforation of  
the cornea in patients [145]. These cells can be used for therapies 
for many human diseases.
Maintaining stem cell microenvironment
Maintainace of  microenvironment in cell culture is highly impor-
tant for regulation of  interactions of  various factors and stem cell 
function. It is also essential for maintaining cellular differentia-
tion, corneal transparency, vision and ocular surface reconstruc-
tion [129]. It is also required for restoration of  important signal-
ing pathways for differentiation of  epidermal/epithelial cells to 
derive specific epithelial cell types [146]. Similarly, limbal niche is 
required for differentiation of  limbal stroma [157] after an injury 
[148]. Further, for derivatization of  tissue-specific stem cells and 
secretion of  regenerative factors and matrix components stem 
cell microenvironment should be maintained for achieving larger 
therapeutic successes [43]. In maintenance of  microenvironment 
extracellular matrix plays a central role in regulating stem cell be-
havior, corneal differentiation, and participation in corneal wound 
healing. These are micro-mini factors participate in various cel-
lular processes and decide cell division patterns in corneal stem 
cell populations. These factors also decide stem cell division as 
asymmetrically or symmetrically. There are certain factors which 
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maintain environmental signals such as cytokines and growth fac-
tors and regulate corneal epithelial stem cells when used for cor-
neal wound healing [149].
Mesenchymal stromal/stem cells (MSCs) are promising stem cell 
type which is used for corneal wound healing and therapeutics 
[43]. Though stem cells exist in different parts of  the eye, such 
as the retina, lens, conjunctiva, corneal stroma, Descemet's mem-
brane but these require ceratin induction factors that could induce 
transdifferentiation of  stem cells into corneal epithelium-like cells 
by in vitro co-culture with immortal corneal epithelium cells. These 
are used as a potential source for ocular surface regeneration 
[150]. However for development of  corneal endothelium pro-
liferating cells should express progenitor markers [151]. Human 
limbal epithelial cells (hLECs) are obtained from organ culture 
of  corneal-scleral (OCCS) rims for therapeutic purposes [148]. 
In addition, spheroids of  rabbit and mouse corneal stromal cells 
(CSCs) are also generated in vitro for reprogramming, bioprinting 
and tissue engineering [152]. These positively express the mesen-
chymal and stem cell phenotypes.
It is clear that niche factors are highly important in the mainte-
nance and regulation of  stem cells. Morespecifically, limbal stro-
mal cells are also used to maintain niche in in vitro co-cultures 
[153]. Human limbal epithelial cells (HLE) and corneal stromal 
stem cells (CSSC) reside in close proximity in vivo in the corneal 
limbal stem cell niche. Thus, limbal stromal cells with an intact 
cell-cell contact help to maintain LSCs in an undifferentiated state 
in vitro during expansion.These need specific tissue environment 
(niches) similar to stem/progenitor cells reside in eye. RAFT TEs 
are also used for restoration of  limbal niche following ocular sur-
face injury or disease [154]. For therapeutic purposes mesenchy-
mal-like stem cells are derived from limbal area of  the corneal 
stroma [155]. Limbal epithelial stem cells (LESCs) also need spe-
cific niche to maintain the transparent ocular surface required for 
vision. This micro-niche is also provided by limbal crypts niche 
for the resident LESCs and associating and dendritic pigmented 
limbal melanocytes and elongated limbal stromal cells [156]. 
LSCs (limbal stem cells) were found effective in the treatment 
of  highly difficult human wounds, such as diabetic ulcers, recal-
citrant chronic wounds, and even persistent epithelial defects of  
the cornea. But these cells need limbal-like environment in the 
transplanted area of  cornea [157]. Normally, in cell culture, stem 
cell niche is maintained by physically protected microenvironment 
in close proximity to a variety of  neighbouring niche cells. It leads 
to form epithelial cellular sheets which can be used for treatment 
of  limbal stem cell deficiency [158] mainly for repairing, wound 
healing and regeneration of  corneal tissues [159]. Similar, niche 
environment is also maintained by amniotic membrane during 
culture of  LSCs in medium. Thus, designing and recreation of  
elements of  various stem cell niches mainly 3-dimensional niche 
architectures can be used for having more biocompatible sub-
strates, matrixes, sheets and factors. These can be used for crea-
tion of  defined topographical features in stem cell derived tissues 
and make them more applicable for numerous tissue-engineering 
applications [160].
Limbal stem cell deficiency
Limbal stem cell deficiency (LSCD) occurs due to depletion of  
limbal stem cells that results in corneal blindness [163] and im-
parts poor vision due to corneal neovascularization, epithelial 
defects and impaired corneal wound healing [164]. Both are per-
manent epithelial defects which persist for longer period as impair 
vision [165]. It can be cured by delivering progenitor cells on a 
contact lens and make them viable and effective after transplanta-
tion [166]. Limbal stem cell deficiency is occured due to direct 
destruction of  limbal stem cells or indirectly from altered lim-
bal stromal niche. It is also caused due to severe ocular injuries 
occurred after exposure of  physical environment and chemical 
agents like sulfur mustard (SM) which cause acute corneal ero-
sions and inflammation of  the anterior segment. It also leads to 
invasion of  conjunctival epithelium over the cornea and imposes 
varying degrees of  corneal changes such as neovascularization, 
inflammation and recurrent erosions. Persistent epithelial defects 
and destruction of  basement membrane of  epithelium stops 
stromal healing in pateints [167]. Similarly, lesions on the ocular 
surface destroy the stem cells from the limbus and cause limbal 
stem cell deficiency. LECs (HLA-typed allogeneic) expanded in ex 
vivo can be harvested from the same living-related donors and are 
used to reconstruct ocular surface in cGVHD [168]].
 
Mesenchymal stem cell transplantation [42] or corneal transplan-
tation with cultivated limbal or oral epithelium is best option for 
removal of  limbal stem cell deficiency (LSCD). It has wider ap-
plication in ocular surface reconstruction [169]. But it needs re-
plenishment of  depleted limbal stem cell (LSC) pool by either 
limbal tissue transplantation or use of  cultivated limbal epithelial 
cells (LECs). Similarly, keratolimbal allograft surgery and deep 
anterior lamellar keratoplasty are also used for removal of  lim-
bal stem cell deficiency (LSCD) [170]. Human limbal mesenchy-
mal cells (HLMCs) express cytokeratin 3, Np63 and connexin 43 
(Cx43) and are used as feeder layer for the human limbal epithelial 
cells (HLECs) [171]. HLMCs are used as a bioengineering prod-
uct which is biologically safer and used for the clinical applica-
tions [172]. LSCD is also related to defects in lens [123] and arises 
due to infectious keratitis [173]. For treatment of  LSCD pateints 
cultivated corneal limbal epithelial transplantation (CLET) and 
autologous tissue transplantation is also used for ocular surface 
reconstruction [174]. Hence, for regeneration elimination of  xen-
ogeneic components is highly important [175]. Boston Kpro is 
also used for restoration of  short-term visual and anatomical cor-
rections in patients with bilateral LSCD [90]. HSPC (Hematopoi-
etic stem/progenitor cell) transplantation is done for to treatment 
of  corneal defects in cystinosis pateints [21].
Stem cell therapy
Stem cells are self  renewal cells which enormously devide to form 
to any cell type. These are used as a source of  new, healthy spe-
cialized cells to replace damaged cells in the eye. There are several 
stem cell types which could be used in different ways, depending 
upon the particular disorder to be treated. Stem cells are used 
in conventional corneal transplantation, to restore cellular layer 
of  the cornea [176]. Stem cell (SC) therapy is used for treating 
various eye defects/pathologies mainly ectopic injuries. It is also 
found successful in treating inherited diseases/disorders, and even 
in case of  acquired cellular deficiencies and neuronal disorders. 
For repairing visual defects neural progenitor cells are delivered to 
the vitreous layer that can integrate into the ganglion cell layer of  
the retina. These cells turn on neurofilament genes, and migrate 
into the host optic nerve. Stem cell therapy is used for treatment 
of  various eye-specific pathologies mainly in retinal degenerative 
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diseases. Stem cells also show potential for the production of  new 
biological components that can be used to repair the eye mainly 
for suitable regenerative medicine for cornea. Stem cells are used 
for replacing the lost retinal ganglion cells and restoration of  pho-
toreceptors.
Biological matrix is used for stem cell growth and transfer that 
could be possible by using co-culture system [161]. By using hu-
man corneal stromal stem cells (dhCSSCs) dorsal root ganglion 
neurons (DRG) can be differentiated that can restore normal 
cornea functions [177]. Besides this, engineered transplantable 
stem cells are also transferred for therapeutic purposes to restore 
patient-specific cornea or lens functions [39]. Normally mamma-
lian cornea contains a population of  basal epithelial stem cells 
which maintain cornea homeostasis and repair [100]. Induced 
pluripotent stem (iPS) cells are also used to replace defective op-
tical tissues and cells. These cells can be derived from autono-
mous fibroblasts by using multiple ectopic transcription factors in 
culture medium. Recently, ciliary body epithelial cells (CECs) are 
identified as a new cell type for iPSC (induced pluripotent stem 
cell) generation that has higher reprogramming efficiency in com-
parison to fibroblasts [178]. Besides, interstitial cell-telocyte which 
possesses outgrowth prolongations named as telopodes form het-
erocellular networks are also used for therapeutic purposes [179]. 
Optic stem cell therapy seems a good best hope for regeneration 
of  permanently damaged cells. However, its treatment needs con-
tinious drug treatments or other exogenous biomaterial implants 
depending upon the relevant ophthalmological condition (Figure 
4).
Human embryonic stem cells (hESCs)
Human embryonic stem cells (hESC) are used as important re-
source to obtain any differentiated cell type of  the human body 
[72]. These cells are used for development of  lens and its regen-
eration [131]. Human embryonic stem cells differentiate to form 
human trabecular meshwork of  stem cells are used in therapeutics 
of  glaucoma [180]. Umbilical cord blood mesenchymal stem cells 
are also used for transplantation purpose to replace injured corne-
al endothelium. These cells behave like human corneal endothe-
lial cells (HCEC) and show ability to heal ex vivo corneal wounds 
[181]. These cells are used to replace damaged or diseased corneal 
endothelium [181]. For cell transplantation specific microenviron-
mental conditions are required for repairing and wound healing. 
Human mesenchymal stem cells also differentiate into soft tis-
sues mainly photoreceptor cells [182] while embryonic stem (ES) 
cells could derive neural retinal lineage cells which can be used to 
form retinal pigment epithelial (RPE) cells and lens cells [183]. 
No doubt embryonic stem cells become an important resource of  
any differentiated cell type of  the human body and can provide a 
limitless supply.
Pluripotent stem cells
Pluripotent stem cells are self  renewable cells which can give rise 
keratocytes that can be used for treatment of  corneal stromal 
opacities. Its differentiation takes place in vitro that can be induced 
by co-culture of  mouse PA6 fibroblasts in the same medium 
[170]. Similarly, induced pluripotent stem (iPS) cells are estab-
lished from somatic cells for generation of  corneal epithelial cells 
[184]. These could be derived from human adult dermal fibroblast 
(HDF)-derived co-culture. Similarly, human adult corneal limbal 
epithelial cells (HLEC) could be derived from iPS cells (L1B41) 
in presence of  Yamanaka 4 factors [184]. This strategy is highly 
successful for generation of  corneal epithelial cells from human 
iPS cells. This is purely epigenomic in origin in which certain ex-
ogenous factors may induce differentiation of  epithelial cells into 
corneal epithelial cells [184].
Mesenchymal stem cells/multipotent marrow stromal cells 
(MSC)
Mesenchymal stem cells are multipotent cells which are found in 
various tissues. These are non-hemopoietic cells, self-renewable 
which can be isolated and expanded in vitro conditions and trans-
differentiate into other type of  cells. These cells reside in bone 
marrow (BM) and support homing of  hematopoietic stem cells 
(HSCs) and their self-renewal. These cells are used for repairing 
of  tissues/cells (essentially those originating from mesoderm). 
These cells indirectly assist in modulating inflammatory and im-
mune responses and used for treatment of  various pathological 
conditions especially for corneal reconstruction [185]. Mesen-
chymal stem cells obtained from diverse tissues show immuno-
suppressive and pro-anti-inflalammatory characteristics [186]. 
Mesenchymal stromal cells (MSC) are quite similar to bone mar-
row-derived mesenchymal stromal cells (BM-MSC). These can be 
grown from the limbus of  the human cornea [187]. These cells 
can be used as supportive cells to facilitate hematopoietic stem 
cell engraftment and to minimize the deleterious consequences 
of  graft versus host disease by their immunosuppressive function. 
These cells show robust osteogenic differentiation capacity and 
are used in healing/repairing of  cutaneous defects due to burns 
or ischemic strokes. 
Besides bone marrow mesenchymal stem cells are isolated from 
various tissues. These are administered to repair injured cornea 
mainly for its reconstruction, but not to the normal cornea. 
Similarly, systemically injected syngeneic mesenchymal stem cells 
(MSCs) are used in transplanted cornea, suppress induction of  
alloimmunity, and promote allograft survival [188]. This admin-
istration of  MSCs showed significant and rapid corneal epithelial 
regeneration under specific stem cell (SC) niche [189]. However, 
expression of  stage-specific embryonic stem cell (ESC)-like prop-
erties of  these cells can be used for new cell based therapeutics 
[55]. Mesenchymal stem cells reside in the murine corneal stroma 
differentiate into chondrocytes and neurocytes which are used in 
keratopathies [190]. Presence of  multipotent human limbal stro-
mal cells resembling mesenchymal stromal cells (MSC) show very 
high therapeutic potential [191] and facilitate the regeneration of  
injured tissue [192]. These beneficial effects of  hMSCs on tissue-
endogenous stem cells involving hCEP (human corneal epithelial 
progenitor cells), provide a basis for using MSCs or MSC-derived 
factors to treat diseases of  the cornea and other tissues [192]. 
Mesenchymal stem cells (MSC) cells are good source for bioen-
gineering of  corneal tissue and for cell-based therapeutics. MSCs 
participate in tissue repairing by modulating excessive immune re-
sponses in various diseases MSCs are used for corneal healing and 
regeneration. These show wider therapeutic applications in mu-
rine models [193]. MSCs protect the ocular surface by suppressing 
inflammation in DES (Dry eye syndrome) and are used in therapy 
for a number of  ocular surface diseases where inflammation plays 
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a key role [193]. Chronic inflammation and neovascularization on 
the ocular surface may accelerate the disappearance of  the am-
niotic membrane [194]. Mesenchymal stromal cells (MSCs) cul-
tivated from the corneal limbus (L-MSCs) are potential source 
of  cells required for corneal repair. Cultivated limbal epithelial 
transplantation is done to restore ocular surface burn [195]. Hu-
man limbal mesenchymal cells (LMCs) are used to support the ex-
pansion of  human corneal epithelial stem/progenitor cells (LSCs) 
in culture [196].
Mesenchymal stem cells (MSCs) differentiate into tissues of  mes-
enchymal origin, and derive different cell types such as fibroblasts, 
adipocytes, cardiomyocytes, and stromal cells. These cells ex-
press surface molecules like CD13, CD29, CD44, CD73, CD90, 
CD166, CXCL12 and toll-like receptors (TLRs) [197]. These cells 
display properties similar to mesenchymal stem cells and demon-
strate the ability to reproduce an organized matrix in vitro. CSSCs 
have shown great potential for the development of  cell-based 
therapies for corneal blindness and stromal tissue bioengineering 
[198]. Therefore, correct specification of  cell lineages is essen-
tially needed within the developing cornea for normal vision [45]. 
Umbilical mesenchymal stem cell transplantation is a promising 
treatment that involves keratocyte renewal or replacement. But 
there is a need to develop alternative treatment regimens for con-
genital corneal diseases of  genetic mutation particularly related to 
corneal blindness [199]. For this purpose, keratoplasty is the most 
effective treatment but there is a lack of  donated cornea that pre-
vents corneal transplantations. Umbilical mesenchymal stem cells 
can be easily isolated, expanded and stored in liquid nitrogen, and 
can be quickly recovered from when a patient is in urgent need. 
Mesenchymal stem cells can transdifferentiate into corneal epi-
thelial cells which are used to restore experimental limbal stem 
cell deficiency in rabbits [200]. More often, modulatory effect of  
rat bone marrow mesenchymal stem cells (MSC) on human cor-
neal epithelial cells (HCE-T) is stimulated with pro-inflammatory 
cytokines interferon gamma (IFN-γ) and tumor necrosis factor 
alpha (TNF-α) [201]. Further, different factors, such as TGF-β, 
IL-10, IDO, PGE-2, sHLA-G5, HO, and Galectin-3, secreted by 
MSCs, induce cell to cell interaction and generate immunomodu-
latory effects on innate and adaptive cells of  the immune system 
[197]. Both cell-cell contact inhibition and transforming growth 
factor-beta2 (TGF-β2) in aqueous humor may be responsible for 
maintaining human endothelial cells in a non-replicative state in 
vivo [202]. Contrary to this, human limbal explants can be gen-
erated in a cholera toxin-free medium with no feeder cell layer 
[203]. Superficial limbal explants are also used to promote the 
surgical treatment of  fungal keratitis [204]. Neural colonies (neu-
rospheres) can be generated from adult corneal limbus in vitro 
[205]. Defective corneal development causes secondary defects 
in lens due to defective migration of  peri-ocular Nrp2+ neural 
crest/mesenchymal cells [206]. 
 
Human corneal epithelium contains self-renewal cells and can be 
maintained by setting a regular microenvironment in the limbus. 
These cells nurture in a specific microenvironment or limbal cell 
niche that can generate stromal cells similar to fibroblasts [207]. 
Under a suitable micro-niche bone marrow mesenchymal stem 
cells (MSCs) transdifferentiate into corneal epithelial cells and are 
used in limbal stem cell deficiency (LSCD) [208]. Limbal stem cell 
deficiency (LSCD) may also relate to aniridic keratopathy (AK) 
with minimally affected irides [209]. However, destruction of  
the limbal epithelium barrier is the most important mechanism 
of  pterygium formation [205] and both primary and secondary 
corneal endothelial decompensation leads to stromal edema, cor-
neal opacity and loss of  visual activity [205]. These cells found in 
basal layer of  the limbus that found in a narrow transition zone 
segregates the peripheral cornea from the adjacent conjunctiva 
[210]. It is also required for vascular regeneration of  corneal and 
retinal cells [211]. MSCs induction by CSCs (corneal stem cells) 
that transdifferentiate into corneal epithelial cells also needs pres-
ence of  fibroblast growth factor 2 and transforming growth fac-
tor β for maintain microenvironment to form endothelial-mes-
enchymal transition (EnMT). This endothelial wound-healing is 
also maintained by cell migration toward artificial wound defects 
mediated by p38 and c-Jun N-terminal kinase [212]. There occurs 
potential difference in fibroblast phenotype across the anterior 
segment of  the human eye because of  certain factors that support 
the regenerative function of  human limbal epithelial progenitor 
cells (LEPs) during wound healing [213]. 
Mesenchymal stem cells (MSCs) are also isolated from the pla-
centa, specifically from the amniotic membrane. These are used 
to treat corneal alkali burn and the reconstruction of  the corneal 
surface. Thus amniotic membrane has been clinically applied as a 
therapeutic material in wound covering and corneal surface recon-
struction. Ceratin other factors such as Sox2, Oct-4 and Nanog 
are also required for AMSCs (amniotic membrane stem cells) dif-
ferentiation into neuronal-like cells. These are a promising source 
of  stem cells and are extensively used in the field of  regenerative 
medicine [214]. Meanwhile after mesenchymal stem cell trans-
plantation expression of  ABCG-2, β(1)-integrin and connexin 43 
is also required to maintain their stem cell character so that they 
can transdifferentiate into epithelial progenitor cells. MSCs condi-
tioned media was found to inhibit the wound healing activities of  
corneal stromal fibroblasts in vitro. In addition, putative factors se-
creted by MSC could be developed for therapeutic use in corneal 
repair [215]. In Moreover, colonization efficiency of  PEA-based 
copolymers in combination with extracellular matrix coatings has 
been evaluated in vitro for derivatization of  mesenchymal stem 
cells from human adipose tissue (h-ADASC). Further, feasibility 
of  adipose-derived mesenchymal stem cells (ADMSCs) that dif-
ferentiate into corneal epithelium-like cells after transfection with 
Pax6 gene is also being checked [39]. Macroporous membranes 
composed of  the optimal PEA subtypes (poly(ethyl acrylate) and 
coating proteins are tested after implanting them inside rabbit 
cornea [216]. 
MSCs are promising candidates for immunomodulatory therapy 
and are being tested successful in several organ transplant rejec-
tion models [217]. These act as bioreactors of  soluble factors 
which promote tissue regeneration in damaged tissues. These 
(MSC) cells perform distinct functions such as prompt wound 
healing, anti-inflammatory, immunoregulatory capacity and elicit 
immunosuppressive effects in a number of  situations. These are 
immunoprivileged cells, which display low expression of  major 
histocompatibilty complex (MHC-II) and its costimulatory mole-
cules on cell surface. These cells also interfere in different immune 
pathways to respond by means of  direct cell-to-cell interactions 
and soluble factor secretion [218]. MSCs are also used for treat-
ment of  many ocular diseases, such as corneal diseases, uveitis 
and retinal diseases [219]]. These are most appropriate candidates 
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used in cell therapy and potentially used in veterinary regenerative 
medicine [220]. 
Mesenchymal stem cells (MSCs) reside in different body tissues 
and can be obtained from bone marrow, skeletal muscle, dental 
pulp, bone, umbilical cord and adipose tissue. These cells can 
form many cell types such as retinal pigment epithelial cells, cor-
neal keratocytes, osteosarcoma and microvascular endothelial 
cells by exposing them with different physical chemical factors 
[221]. Mesenchymal stem cells generate potential beneficial fac-
tors that make corneal recovery possible. For this purpose MSCs 
are seeded on a xenogeneic acellular corneal matrix (ACM) in vitro 
[219] in a suitable microenvironment. The secreted corneal ma-
trix can be used as a substitute for healing corneal wounds [219]. 
However, post-operative injection of  MSCs could inhibit kerato-
plasty rejection and prolong the corneal allografts survival in a rat 
model [219]. 
Allogeneic cultivated limbal epithelial cells are also transplanted 
into the recipient eye for restoration of  visual defects [222] but 
they need human amniotic membrane as a carrier. Limbal basal ep-
ithelial cells serve as niche cells and assist in generation of  various 
cell progenitors. These form diverse cell types which participate in 
tissue regeneration and corneal wound healing [201]. However, by 
nurturing these cells under a suitable biological niche these cells 
could facilitate corneal epithelial regeneration by providing physi-
cal support and chemical signaling [201]. Similar, niche also plays 
critical role in maintaining stem cell differentiation [223]. Adipose 
tissue derived mesenchymal stem cells show expression of  epi-
thelial markers i.e. CD34, CD90, p63, and ABCG2 and CK3/76, 
CK12, CK76, CK19, and CK1/5/10/14. These also display ex-
pression of  putative stem cell markers (CD90, ABCG2, and p63) 
and cytokeratins (CK12 and CK76). These markers provide self-
renewal capacity and intrinsic plasticity to adipose tissue derived 
mesenchymal stem cells. After cellular differenetiation these cells 
acquire some epithelial-like characteristics. Due to their high self  
renewal capacity adult ADSCs (adipose-derived stem cells) cells 
are used as a potential source for cell therapy in ocular surface 
regeneration [224]. Stromal cell secreted soluble factors/ growth 
factors are used to establish micro-niche of  corneal epithelial 
stem cells. But in in vitro cultures epithelial cells organize to form 
epithelial clusters and make sheet like structures which upon dis-
lodging by gentle enzymatic digestion separate into transplantable 
cell population [203]. Limbal stromal niche cells heterogeneously 
express embryonic stem cell (SC) markers [225]. Limbal stem cells 
are used for restoration of  corneal transprency. Corneal limbal 
stromal progenitor cells are used as autologous cell source to pro-
duce functional neurons [226]. 
Corneal allotransplantations are also done by intravenous infu-
sion of  human MSCs (hMSCs) [227]. These cells are derived 
from homing of  human umbilical cord blood and are used for 
injured or diseased corneal endothelium [179]. MSCs are also 
derived from human amniotic membranes ex-utero for corneal 
therapy [228]. MSCs are also used as alternative for corneal grafts 
and a biological matrix for limb cells cultures used to regenerate 
the corneal lesions. These cells remain viable and reconstruct a 
stable ocular surface. Similarly, cultivated oral mucosal epithelial 
transplantation (COMET) is used for treatment of  eyes with to-
tal limbal stem cell deficiency [229]. Hence, normal regeneration 
and epithelialization of  the corneal surface is highly important for 
obtaining a satisfactory long-term outcome, and lower down the 
transplantation failures and other complications [229]. By using 
explants cultures epithelial-mesenchymal transition can be made 
for intrastromal transplantations [230]. 
Human limbus tissue is used for deriving epithelial stem cells, 
and stromal fibroblast-like stem cells [231]. These cells secrete 
and organize a thick stroma-like extracellular matrix in response 
to different substrata, but neither cell type organizes matrix on 
tissue-culture polystyrene [232]. Both human corneal stromal 
stem cells (hCSSCs) and human corneal fibroblasts (hCFs) are 
used for generation of  human corneal stromal tissue. Their cul-
ture is maintained on a highly-aligned fibrous substrate made up 
of  poly (ester urethane) urea. These cells are also maintained in 
the serum-free medium supplemented with FGF-2 (10 ng/mL) 
and TGF-β3 (0.1 ng/mL). Human corneal stromal stem cells (hC-
SSCs) are successfully differentiated into keratocytes which form 
multilayered lamellae with orthogonally-oriented collagen fibrils 
[233]. Moreover, for cellular differentiation of  stem cells progeni-
tors need induction from certain factors that are added in culture 
media [55]. 
Multipotent mesenchymal stromal cells (MSCs) found in number 
of  tissues. Mesenchymal stem cells (MSCs) are used to contruct 
ocular surface and are subconjunctivally administered on corneal 
wound healing in the acute stage of  an alkali burn [234]. These 
are widely used in tissue engineering, immunology, gene therapy, 
and oncology [235]. MSCs significantly accelerate corneal wound 
healing and attenuate inflammation and reduce CNV (corneal ne-
ovascularization) in alkaline-burned corneas. These cells influence 
cell proliferation and growth factor expression of  corneal lim-
bal epithelial cells (LECs) in vitro [236]. Further, down-regulation 
of  MIP-1α, TNF-α and VEGF influence cell proliferation [234]. 
Similarly, SDF-1α-induced progenitor cell recruitment and mac-
rophage VEGF production plays critical role in the experimental 
corneal neovascularization [237]. In addition, systemic adminis-
tration of  adult stem/progenitor cells (MSCs) reduces inflamma-
tory damage to the cornea without engraftment and primarily by 
secretion of  TNF-α stimulated gene/protein 6 [238]. 
Retinal pigment epithelial cells and photoreceptor progenitors 
(lens cells) are used for treatment of  retinal diseases mainly for 
treatment of  cataract. Retinal pigment epithelial and lens cells are 
derived from non optic retinal progenitor-like cells. These cells 
display similar cell surface markers [239]. A rare population of  
pigmented cells derived from retinal stem cell is also identified in 
the ocular ciliary body (CB) of  adult mammals. These cells clon-
ally proliferate and expand to generate pigmented sphere colo-
nies (PSC) in vitro and form epithelial progenitor-like cells [240]. 
Embryonic stem cell using stromal cell-derived induce cellular 
proliferation both in vitro and in vivo. Similarly, BM cell types may 
infiltrate into injured and/or diseased tissues and subsequently 
differentiate to form phenotypes of  residential cells when inject-
ed. These cells are also used to repair damaged tissue sending via 
circulation to generate a keratocyte phenotype [237]. 
Tissue bioengineering
Bioengineered corneal tissues are used as prosthetic devices for re-
placement of  the cornea and restoration of  its functions. Though 
there are difficulties of  immune rejection and shortage of  organ 
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supply for corneal transplantation. Besides, natural keratoplasty, 
artificially developed cornea is also used to replace damaged one 
but it shows low biocompatibility. There is an increasing demand 
of  bioenginreed corneal tissues for surface reconstruction and 
transplantation purposes. These are used with tissue-engineered 
hydrogels which assist in fast regeneration. Hence, to meet out the 
shortage of  donor corneas for transplantation, particularly in de-
veloping countries, bioengineered corneal tissues are used in form 
of  explants for tissue therapy. For mass production of  low-cost 
bioengineered corneas new methods are developed and standard-
ized. These corneas attribute near about similar transparency and 
compatibility to natural corneas and with host cells. BPCs (bio-
engineered prosthetic corneas) fabricated into hydrogel corneal 
implants provide over 90% transparency and four-fold increase 
in strength and stiffness compared with previous versions [55]. 
These tissue engineered corneal transplantations have shown very 
high success to treat blinding diseases [241]. 
Further, bioengineering technology has evolved new scaffolds/
biomaterials which are used in reconstructing corneal epithelium. 
However, for promoting interactions between neurons and corne-
al tissue co-culture methods are also developed. More specifically, 
collagen vitrigel (CV) is used for reconstructing corneal epithe-
lium in the stromal wound and limbal stem cell deficiency (LSCD) 
[242]. It is also is used as a scaffold material for for hLEC (Hu-
man Lymphatic Endothelial Cells) transplantation without having 
complications [242]. It supports corneal epithelial differentiation 
and prevents epithelial hypertrophy. Similarly, nanofibers pre-
pared from copolymer PA6/12 represent a convenient scaffold 
(Table 3) for growth of  LSCs (limbal stem cells) and MSCs and 
transfer to treat SC deficiencies and various ocular surface injuries 
[243]. Moreoften, copolymer PA6/12 nanofibers displays stability 
in aqueous solutions, biocompatibility as good matrix that sup-
ports growth of  LSCs (limbal stem cell) [243]. Similarly, Bombyx 
mori silk fibroin is also used as a substrate for human limbal epi-
thelial (L-EC) and stromal cell cultivation. 3D engineered limbus 
constructed from B. mori silk fibroin, showed potential benefits in 
corneo-limbal tissue regeneration [182]. Dual-layer fibroin scaf-
folds are also prepared by using L-EC and L-MSC secreted matrix 
and polylactic-co-glycolic acid (PLGA)(Table 3) for repairing cor-
neal stromal defects [179].
Corneal stroma is an avascular connective tissue that is character-
ized by layers of  highly organized parallel collagen fibrils which 
are mono-disperse in diameter with uniform local interfibrillar 
spacing. Natural corneal stroma is used as an optimal substrate 
to construct a natural corneal equivalent to repair eye defects. For 
this purpose human corneal epithelium is cultured from donor 
limbal explants on corneal stromal discs that are prepared by FDA 
approved Horizon Epikeratome system. More specifcally, autolo-
gous rASCs (autologous rabbit adipose derived stem cells) are 
used as cell source for corneal stromal restoration. Mainly autolo-
gous rASCs-PLGA constructed corneas have been developed by 
following tissue engineering methods. These are transparent and 
without corneal neovascularization [179]. Adipose-derived stem 
cells (ADSC) express keratocyte-specific phenotypic markers and 
express corneal-specific matrix components. These cells are culti-
vated in controlled conditions to support and induce differentia-
tion to form keratocytes [244]. ADSC (adipose derived stem cells) 
are potentially used in corneal cell therapy and tissue engineer-
ing [245]. Similarly, human bone marrow mesenchymal stem cells 
(hMSC) are allowed to differentiate into corneal epithelial-like 
cells after induction. These cells are also used in corneal tissue 
engineering [56]. Thus, bioengineered spatially complex, collagen-
based nano-structured constructs are used for corneal repairing 
and regeneration [246]. Similarly, bioengineered synthetic corneal 
tissue derived from corneal stromal stem cells of  human origin is 
also used as a quality biomaterial for corneal reconstruction [247]. 
Corneal epithelium is used to make tissue-engineered human un-
differentiated immature dental pulp stem cells (hIDPSC) sheet 
and to make reconstructs for transplantation in vitro by maintain-
ing limbal stem cells cultured onto human keratoplasty lenticules 
(HKLs). Thin collagen matrix and fibroblast-like cells are used 
in keratoplasty mainly in repairing of  retrocorneal membranes 
(RCMs). HKL is a suitable scaffold material to obtain natural 
corneal graft for clinical purposes [248]. It induces prolifera-
tion, express differentiation markers. It binds to the underlying 
stroma with no alterations in clonogenic potential. HKLs allow 
cell growth with no feeder layers, and freeze dried, to preserve 
integrity and viability of  stromal keratocytes [248]. Hevin is a ma-
tricellular protein that is used in tissue repair and remodeling via 
interaction with the surrounding extra cellular matrix (ECM) pro-
teins [249]. Hevin is transiently expressed in the IrrPTK-injured 
corneas. Its loss predisposes aberrant wound healing and gen-
erates severe chronic inflammation and stromal fibrosis. Hevin 
plays a pivotal role in the corneal wound healing [249]. Electro-
spin is used for making constructs using rabbit limbal epithelial 
and stromal cells [56]. It is a biodegradable membrane made up 
of  poly (lactic-co-glycolic acid) 50:50, which incorporates the fea-
tures of  the underlying microfabricated structures. More recently, 
tissue-engineered hemicornea is also used for therapeutic purpose 
in pateints which show total limbal stem cell deficiency [176].
 
Tissue-engineered cell sheets are used for ocular surface recon-
struction in animal models mainly having total limbal stem cell 
deficiency (LSCD) [250]. For designing new tissue engineering 
scaffolds and long-term success of  implants complete regula-
tory information is needed on cell signaling after damaging ocular 
surface in the experimental animals [43]. In experimental animal 
models cornea is damaged by a variety of  clinical, chemical, me-
chanical, and thermal injuries. However, to prepare tissue engi-
neered corneal substitutes (TEC) for treatment of  corneal surface 
defects induced bone marrow mesenchymal stem cells (BMSCs) 
of  corneal lineage are used [251]. In addition, carrier materials 
such as collagen, fibrin, siloxane hydrogel, poly(ε-caprolactone), 
gelatin-chitosan, silk fibroin, keratin, poly(lactide-co-glycolide), 
polymethacrylate, hydroxyethylmethacrylate and poly(ethylene 
glycol) (Table 3) are potentially used for treatment of  limbal stem 
cell deficiency [252]. Corneal reconstruction is among the most 
effective methods for curing clinical disorders [163]. 
Stem cells are also used to generate neogenetic structure from a 
lineage of  bone marrow-derived mesenchymal stem cells [253]. 
Today nonbiological corneal substitutes such as poly (ethyl 
acrylate) (PEA)-based copolymers, extracellular matrix-protein 
coating are used for increasing the survival rate of  grafting tissues. 
Colonization with adipose-derived mesenchymal stem cells has 
also increased the survival rate of  grafts. In addition, for obtain-
ing good results and longer survival human adipose tissue derived 
mesenchymal stem cells (h-ADASC) and PEA-based copolymers 
are used in combination with extracellular matrix coatings and 
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macroporous membranes composed of  the optimal PEA sub-
types and coating proteins. PEA with low hydroxylation as a scaf-
fold also gives good results [218] (Table 3). 
Human corneal stromal stem cell (hCSSCs) when cultured on 
biodegradable poly(ester urethane)urea (PEUU) get differentiated 
to keratocytes. These are also used to produce abundant matrix 
that helps in organization of  the transparent connective tissue 
of  the corneal stroma by differentiated keratocytes. Similarly, hu-
man mesenchymal stem cells (MSC), cultured without any feeder 
layer (NF) show derivatization of  cornea epithelial that is used for 
making constructs mainly for xenografts [254]. MSCs cultured on 
nanofiber scaffolds provide protection from formation of  toxic 
peroxynitrite. It lowers the apoptotic cell death and decreased ma-
trix metalloproteinase and pro-inflammatory cytokine production 
which lower down corneal inflammation as well as neovasculari-
zation and significantly accelerated corneal healing [255]. Corneal 
epithelial stem cells (SCs) need more adaptable niche to differenti-
ate into limbal palisades of  Vogt, located between the cornea and 
the conjunctiva. But limbal stem cells also require close physical 
association with their native NCs via SDF-1/CXCR4 signaling 
for appropriate differentiation [230]. However, for management 
of  corneal limbal stem cell deficiency Boston type I keratopros-
thesis is followed [256]. Prior to CLSC (Cord Lining Stem Cells) 
transplantation anti-lymphangiogenic treatment is also required 
[57]. Surface treatment to a biomaterial surface modifies cell type 
and accelerates the cell growth [256]. However, for generation of  
complex organ structures mainly any eye component it will re-
quire the intricate orchestration of  multiple cellular interactions. 
Few genes linked to Lhx2's function in the expansion and pattern-
ing of  progenitor cells have been identified [257]. 
Conclusion
Neonatal eye defects are seen at global level and notified as impor-
tant congenital eye defects. There neonatal visual defects either 
developmental, mainly secondary to genetic conditions or due to 
use of  drugs, alcohol or maternal blood sugar. There are certain 
genetic disorders and defects of  eye lid, cornea, iris and pupil, 
choroid and retina, visual nerve which are a leading cause of  visu-
al impairment in children. There are also problems of  poor vision 
with no apparent cause. Stem cells possess enormous potential to 
replace defective tissues and treat various pathological conditions. 
For tissue repairing and its regeneration artificial cell systems 
have been developed for construction of  tissues both directly by 
providing repair cells and indirectly by modulating inflammatory 
and immune responses. Transplantation of  keratoplasts, epithelial 
sheets, biomatrix and new biocompatible scaffold materials are 
also essentially required for restoration of  eye defects. These scaf-
folds are used in corneal transplantation to treat blinding diseases 
like Limbal stem cell deficiency (LSCD). Few important silk fi-
broin scaffolds, poly (ethyl acrylate) (PEA), polylactic-co-glycolic 
acid (PLGA) are bioenginnered are used as important biomateri-
als for repairing corneal stromal defects. Further, for good thera-
peutic successes major reasons of  neonatal eye defects such as 
chromosomal abnormalities, genetic mutations, infection, and 
prenatal drug exposure should be established in animal models. 
There was felt an urgent need of  new matrix designs, scaffold 
materials and extracellular matrix remodeling for neonatal eye de-
fects. Use of  appropriate nutritients and drugs were found some-
what preventable and to reduce congenital malformations. An 
earlier red reflex screening and physical examination of  newborns 
is highly suggestive to short out ophthalmologic abnormality and 
to reduce mental stress and pain. Corneal pathological effects 
related to one or all of  the corneal layers that produce corneal 
opacity can be removed by using stem cells. Moreover, by trans-
plantation of  stem cell progenitors, epithelial stem cells can be 
generated for sequestering towards the injury sites for repairing 
of  eye defects in adults. There is an increasing demand of  human 
corneal tissues for surface reconstruction and transplantation. 
There is a worldwide donor tissue shortage and many allogeneic 
grafts are eventually rejected. However, to fulfill demand of  cor-
neal tissue grafts new innovative methods are being developed to 
supplement tissue donation. Due to insufficient cornea donation 
and inherent artificial lens problems, alternative treatment strate-
gies based on stem cell transplantations become boon for visually 
impaired new borns. For cell replacement therapy and transplan-
tation for effective corneal regeneration and reconstruction stem 
cells induced to express markers consistent with multipotency are 
successfully used. Consequently, efforts should be to cutdown 
long-term vision impairments in neonates for quick restoration 
and improving quality of  their life. Hence, for stepwise manage-
ment and therapeutics of  eye related defects, identification of  
disorder based appropriate and authentic biomarkers are to be ex-
plored. All multidisciplinary approaches should apply to treat the 
neonatal patients having eye defects. Lastly, for cognitive and be-
havioral assessments neonates and infants are recommended ad-
equate opthalmological and neuropsychological support for their 
rehabilitation. An early diagnosis and prompt treatment may help 
patients with compressive and toxic ophthalmic-neuropathies.
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